Telemedicine COVID-19 Briefing | McDermott Skip to main content

Telemedicine COVID-19 Briefing

Overview


Government, media and industry have all pointed to the potential for telemedicine to assist in combating the COVID-19 pandemic. In addition, steps have been taken by the government to ease the burdens associated with the use of telemedicine during this crisis. Unfortunately, the complexity of the regulatory infrastructure has left a fair amount of confusion with respect to the extent to which rules have been, and may be, liberalized. At a time when our healthcare infrastructure is engaging with a health crisis that will get worse before it gets better, confusion about the requirements for care delivery needs to be reduced to a minimum.

Please join us for an update on:

  • Loosened Medicare reimbursement requirements
  • State emergency efforts
  • Related issues associated with the delivery of telemedicine services during the COVID-19 pandemic

Registration Information

March 16, 2020

1:00 pm – 2:00 pm (EDT)

 

Dig Deeper

London / In-person / September 24, 2026

HPE Europe 2026

Brussels, Belgium / Speaking Engagements / May 21, 2026

EU Pharmaceutical Law Forum 2026

Nashville, TN / In-person / May 20 - 21, 2026

McDermott HealthEx 2026

Chicago, IL / Speaking Engagements / April 30 – May 1, 2026

17th Annual Advanced Forum on Managed Care Disputes and Litigation

San Francisco, CA / In-person / April 30, 2026

Health Tech Investment Forum 2026

Las Vegas, NV / Speaking Engagements / April 26 – April 30, 2026

Asembia’s AXS26 Summit